Zobrazeno 1 - 10
of 140
pro vyhledávání: '"H. J. Bos"'
Autor:
Xuechun Li, Maarten J. Bijlsma, Stijn de Vos, Jens H. J. Bos, Sumaira Mubarik, Catharina C. M. Schuiling-Veninga, Eelko Hak
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionAntihypertensive drugs are used preventatively to lower the risk of cardiovascular disease events. Comparative effectiveness studies on angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs), beta-blocke
Externí odkaz:
https://doaj.org/article/ebb980d0613a4513a26bd275034428e4
Autor:
E. B. Warreman, L. A. Nooteboom, P. J. M. Leenen, H. M. Geurts, M. B. Terry, J. H. J. Bos, E. Hak, H. W. Hoek, E. F. C. van Rossum, R. R. J. M. Vermeiren, W. A. Ester
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundWhile cardiovascular diseases is highly prevalent and an important cause of mortality in autistic adults, knowledge on their increased cardiovascular risk is limited. Hence, this study aimed to investigate psychological, behavioral, and phy
Externí odkaz:
https://doaj.org/article/5069d787964647b59eafbe3ef1be6574
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Objective To determine the long-term effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events.Design Retrospective inception cohort study covering a 25-year study period.Setting University Groningen IADB.nl pharm
Externí odkaz:
https://doaj.org/article/0978062eeab94bd4a327f2409eafe035
Autor:
Ali Alghamdi, Maarten J. Bijlsma, Stijn de Vos, Catharina C.M. Schuiling-Veninga, Jens H. J. Bos, Eelko Hak
Publikováno v:
Pharmaceuticals, Vol 16, Iss 12, p 1694 (2023)
Background: Alzheimer’s disease (AD) is the most common cause of dementia, with a growing number of patients worldwide. The association between AD and treatment with drugs targeting the beta-adrenergic receptor is controversial. The aim of this stu
Externí odkaz:
https://doaj.org/article/aa5ddc353c8f41599712132501985cc0
Autor:
C. A. M. Hartwig, R. Robiyanto, S. de Vos, J. H. J. Bos, E. P. van Puijenbroek, E. Hak, C. C. M. Schuiling-Veninga
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Recent studies have reported an association between antidepressant (AD) use during pregnancy and the risk to develop attention-deficit/hyperactivity disorder (ADHD) in the offspring. However, the association might be confounded by risk factors in the
Externí odkaz:
https://doaj.org/article/f5a81f8a49c443d5a483be464eb5a383
Autor:
Robiyanto Robiyanto, Catharina C M Schuiling-Veninga, Jens H J Bos, Eelko Hak, Eugène P van Puijenbroek
Publikováno v:
Archives of womens mental health, 26, 39-48. SPRINGER WIEN
Trends in prescribing psychotropic drugs before and during pregnancy may have changed over the years, but actual information is lacking. We therefore compared and assessed the exposure and acceptance rates of classes of antipsychotic (+ lithium), anx
Autor:
Muh. Akbar Bahar, Jens H. J. Bos, Sander D. Borgsteede, Aafje Dotinga, Rolinde A. Alingh, Bob Wilffert, Eelko Hak
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundDrug-drug interaction (DDI) is one of the main contributors to adverse drug reactions and therefore, it is important to study its frequency in the population. We aimed to investigate frequency and concordance on CYP2D6, CYP2C19, and CYP2C9
Externí odkaz:
https://doaj.org/article/0fe60b47876e442bbf49c0c4a06d41cf
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0214240 (2019)
BACKGROUND AND PURPOSE:Polypharmacy is becoming increasingly common owing to the ageing population, which can pose problems for patients and society. We investigated the trends in polypharmacy and underlying drug groups among adults in the Netherland
Externí odkaz:
https://doaj.org/article/1bec11d96d7c4a29b5e3cf960a7b42a5
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 206(5), 625-627. American Thoracic Society
Autor:
Yuanyuan Wang, Jens H. J. Bos, Catharina C. M. Schuiling-Veninga, Eelko Hak, H. Marike Boezen, Bob Wilffert, Job F M van Boven
Publikováno v:
Pharmacoepidemiology and Drug Safety, 31(2), 158-166. Wiley
Purpose Varenicline is an effective treatment for smoking cessation. While clinical trials did not confirm a causal role, case reports suggested a possible link of varenicline with neuropsychiatric adverse drug events (NPAEs). This study aims to inve